Problems With Monitoring of Aseptic Areas and Quality Control Lands Cipla Ltd a Form 483

By PacConAdmin | September 23, 2022

Repeated problems with aseptic areas landed India’s global pharmaceutical company Cipla Limited a Form 483, in addition to new quality and computer control issues.
Source: Drug Industry Daily

Posted in Drug Industry Daily